Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 11;19(2):246-250.
doi: 10.22074/ijfs.2024.2030292.1698.

Investigation of The Placental Levels of Vascular Endothelial Growth Factor B and Selenoprotein P and Their Relation with Birth Weight in Patients with Pre-eclampsia: A Case-Control Study

Hadi Eslahi  1   2 , Mohsen Saravani  3   4 , Mansour Shahraki  1   5 , Abolfazl Payandeh  6 , Mahnaz Rezaei  7   4 , Marzieh Ghasemi  8 , Saeedeh Salimi  9 , Mahjob Sargazi-Taghazi  10
Affiliations

Investigation of The Placental Levels of Vascular Endothelial Growth Factor B and Selenoprotein P and Their Relation with Birth Weight in Patients with Pre-eclampsia: A Case-Control Study

Hadi Eslahi et al. Int J Fertil Steril. .

Abstract

Background: Pre-eclampsia is a serious medical condition characterised by high blood pressure and signs of organ damage that is associated with adverse pregnancy outcomes, including low birth weight. Selenoprotein P (SELENOP) and vascular endothelial growth factor B (VEGF-B) are antioxidants that can improve the condition of this disease. This study aims to investigate the placental levels of SELENOP and VEGF-B, and their association with birth weight in pregnant women with pre-eclampsia compared to healthy pregnant women.

Materials and methods: This case-control study enrolled 30 pregnant women with pre-eclampsia as the case group and 30 healthy pregnant women as the control group. Demographic information and anthropometric indices were collected and recorded in forms. Placental levels of SELENOP and VEGF-B were assessed by a commercial human kit and based on enzyme-linked immunosorbent assay (ELISA). P<0.05 indicated statistical significance.

Results: The mean placental level of VEGF-B in pregnant women with pre-eclampsia was lower than the healthy group (P=0.001) as was the mean placental level of SELENOP compared to the healthy group (P=0.048). No significant correlation existed between placental levels of SELENOP (r=0.253, P=0.051) and VEGF-B (r=0.671, P=0.056) with birth weight.

Conclusion: Our findings showed that pregnant women with pre-eclampsia had lower levels of VEGF-B and SELENOP compared to healthy pregnant women. The findings may assist with pre-eclampsia diagnosis, management, and prediction, and benefit mothers and babies.

Keywords: Pre-eclampsia; Pregnancy; Selenoprotein P; Vascular Endothelial Growth Factor B.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. LaMarca B, Cornelius DC, Harmon AC, Amaral LM, Cunningham MW, Faulkner JL, et al. Identifying immune mechanisms mediating the hypertension during preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2016;311(1):R1–9. - PMC - PubMed
    1. Magee LA, Nicolaides KH, von Dadelszen P. Preeclampsia. N Engl J Med. 2022;386(19):1817–1832. - PubMed
    1. Aramesh Sh, Qaitasi A, Masnavi E, Qaitasi I, Hassanzadeh S. Prevalence of preeclampsia, eclampsia and related factors in pregnant women referred to imam sajjad hospital in Yasuj in 2016. Armaghane Danesh. 2020;25(1):129–139.
    1. Farzaneh F, Tavakolikia Z, Soleimanzadeh Mousavi SH. Assessment of occurrence of preeclampsia and some clinical and demographic risk factors in Zahedan city in 2017. Clin Exp Hypertens. 2019;41(6):583–588. - PubMed
    1. Kane SC, Dennis AT. Doppler assessment of uterine blood flow in pre-eclampsia: a review. Hypertens Pregnancy. 2015;34(4):400–421. - PubMed

LinkOut - more resources